Living with an autoimmune disease often means navigating a lifelong, complex condition. A recent study estimates that ...
Next-generation CAR T-cell therapies aim to improve accessibility, durability, and effectiveness, addressing current ...
Post-CAR T infection prophylaxis should follow European Hematology Association/European Society for Blood and Marrow ...
The latest chemistry news, including important research advances, business and policy trends, chemical safety practices, career guidance, and more. Current approved CAR T-cell therapy treatments rely ...
SAN DIEGO--(BUSINESS WIRE)--Candid Therapeutics, Inc. (“Candid”), a clinical-stage biotechnology company redefining the treatment of autoimmune and inflammatory diseases through novel T-cell engagers ...
Rheumatoid arthritis (RA) is an autoimmune disease that affects millions worldwide and can have a devastating impact on patients' lives. Yet, about one in three patients respond poorly to existing ...
However, details of the intervening steps, as researchers have learned in the past 65 years, are quite complex — certain cells carry the flu antigen to the immune system, specific immune cells respond ...
CD40 is a transmembrane protein belonging to the tumor necrosis factor receptor superfamily. It is predominantly expressed on antigen-presenting cells like B cells, macrophages, and dendritic cells.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback